Oncogene transduction, the process by which a cellular gene is capture
d by a retrovirus, was mainly described invivo. We have developed a bi
ological system allowing stepwise analysis of transduction mechanisms
in tissue culture. Avian neuroretina NR) cells, dissected at the 8th d
ay of embryonic development, rapidly cease to divide and differentiate
in culture. Serial passaging of a retrovirus that does not carry an o
ncogene on such cultures, leads with a high frequency to the emergence
of new viruses that have transduced oncogenes from the mil/raf family
of serine/threonine kinases. These viruses have been selected by thei
r ability to induce NR cells division. This experimental system allowe
d the isolation of the following molecular intermediates generated dur
ing the successive steps of oncogene transduction : a chimeric transcr
ipt containing viral and cellular sequences joined together by an alte
rnative splicing mechanism ; then a complete retrovirus with a 5' end
identical to that of the chimeric RNA ; finally, a retrovirus that has
acquired additional gag sequences, and, consequently, and increased r
eplicative capacity. Structural analysis of these molecules led us to
propose a general model for oncogene transduction in which the key ste
p is the synthesis of chimeric RNAs. This model also explains the gene
ration of the vast majority of acutely transforming retroviruses isola
ted in vivo.